Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?

被引：3
|
作者：
Kourie, Hampig Raphael [1 ]
Awada, Gil [2 ]
Awada, Ahmad Hussein [1 ]
机构：
[1] Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Clin, Brussels, Belgium
[2] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Brussels, Belgium
来源：
FUTURE ONCOLOGY | 2016年 / 12卷 / 04期
关键词：
cancer; checkpoint inhibitors; clinical trial; diagnosis; future; immunotherapies; ipilimumab; nivolumab; pembrolizumab; unknown primary tumor; NIVOLUMAB; ANTI-PD-1; SAFETY;
D O I：
10.2217/fon.15.329
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：429 / 431
页数：3
相关论文
共 50 条
  • [21] Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors
    Ryul Kim
    Bhumsuk Keam
    Sehui Kim
    Miso Kim
    Se Hyun Kim
    Jin Wook Kim
    Yu Jung Kim
    Tae Min Kim
    Yoon Kyung Jeon
    Dong-Wan Kim
    Doo Hyun Chung
    Jong Seok Lee
    Dae Seog Heo
    BMC Cancer, 19
  • [22] Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors
    Kim, Ryul
    Keam, Bhumsuk
    Kim, Sehui
    Kim, Miso
    Kim, Se Hyun
    Kim, Jin Wook
    Kim, Yu Jung
    Kim, Tae Min
    Jeon, Yoon Kyung
    Kim, Dong-Wan
    Chung, Doo Hyun
    Lee, Jong Seok
    Heo, Dae Seog
    BMC CANCER, 2019, 19 (1)
  • [23] Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: Therapeutic implications for immune checkpoint inhibitors
    Kim, Ryul
    Keam, Bhumsuk
    Kim, Sehui
    Kim, Miso
    Kim, Se Hyun
    Kim, Jin Wook
    Kim, Yu Jung
    Kim, Tae Min
    Jeon, Yoon Kyung
    Kim, Dong-Wan
    Chung, Doo Hyun
    Lee, Jong Seok
    Heo, Dae Seog
    CANCER RESEARCH, 2018, 78 (13)
  • [24] Role of Immune Checkpoint Inhibitors in Understudied Populations
    Kadakia, Kunal C.
    Salem, Mohamed E.
    JCO ONCOLOGY PRACTICE, 2021, 17 (05) : 246 - +
  • [25] Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
    Mazloom, Anita
    Ghalehsari, Nima
    Gazivoda, Victor
    Nimkar, Neil
    Paul, Sonal
    Gregos, Peter
    Rateshwar, Janice
    Khan, Uqba
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 23
  • [26] The Role of Immune Checkpoint Inhibitors in Cancer Therapy
    Basudan, Ahmed M.
    CLINICS AND PRACTICE, 2023, 13 (01) : 22 - 40
  • [27] The Role of Immune Checkpoint Inhibitors in Colorectal Adenocarcinoma
    Daniel R. Almquist
    Daniel H. Ahn
    Tanios S. Bekaii-Saab
    BioDrugs, 2020, 34 : 349 - 362
  • [28] Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
    Zhang, Zeng
    Tan, Xin
    Jiang, Zengxin
    Wang, Hao
    Yuan, Hengfeng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] The role of immune checkpoint inhibitors in prostate cancer
    Surdacki, Gabriel
    Szudy-Szczyrek, Aneta
    Goracy, Aneta
    Chyl-Surdacka, Katarzyna
    Hus, Marek
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2019, 26 (01) : 120 - 124
  • [30] The Role of Immune Checkpoint Inhibitors in Colorectal Adenocarcinoma
    Almquist, Daniel R.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    BIODRUGS, 2020, 34 (03) : 349 - 362
12345